BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24735938)

  • 1. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
    Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
    J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
    Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
    Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
    Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
    BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.
    Park J; Park S; Song C; Hong JH; Kim CS; Ahn H
    World J Urol; 2014 Feb; 32(1):157-63. PubMed ID: 23568447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy.
    Sano T; Kato M; Sassa N; Sadachi R; Hirakawa A; Kamihira O; Hirabayashi T; Nishikimi T; Katsuno S; Kimura T; Hattori R; Gotoh M; Tsuzuki T
    Virchows Arch; 2021 Jun; 478(6):1089-1097. PubMed ID: 33420835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma.
    Yoshimura K; Arai Y; Fujimoto H; Nishiyama H; Ogura K; Okino T; Ogawa O
    Cancer; 2002 Jun; 94(12):3150-6. PubMed ID: 12115347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification.
    Sassa N; Tsuzuki T; Fukatsu A; Majima T; Kimura T; Nishikimi T; Yoshino Y; Hattori R; Gotoh M
    Histopathology; 2012 Oct; 61(4):620-8. PubMed ID: 22730905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
    Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
    J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
    J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
    Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
    Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma].
    Bruzzi M; Le Goux C; Pignot G; Amsellem-Ouazana D; Vieillefond A; Patard JJ; Zerbib M
    Prog Urol; 2014 Jul; 24(9):556-62. PubMed ID: 24975790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
    Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
    J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tumor location on oncologic outcomes in patients with upper urinary tract urothelial carcinoma stratified by pathologic stage.
    Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
    Urol Oncol; 2016 Jan; 34(1):4.e19-25. PubMed ID: 26351152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Pelvic Urothelial Carcinoma With Invasion Into Renal Medulla Can Be Redefined as pT2 to Improve Correlation With Survival.
    Wong MN; Wu DJ; Lee CT; Zynger DL
    Mod Pathol; 2023 Jun; 36(6):100140. PubMed ID: 36813117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
    Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; CompĂ©rat E; RouprĂȘt M
    Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.